← FDA Drug Approvals (Drugs@FDA)

ULTRAGRIS-330

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PLIVA · Approved 1992-06-30

Drug application

FDA Application #

ANDA062646

Application type

Abbreviated New Drug Application (Generic)

Brand name

ULTRAGRIS-330

Generic name

Griseofulvin, Ultramicrocrystalline

Active ingredients

GRISEOFULVIN, ULTRAMICROCRYSTALLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PLIVA

First approval

1992-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown